Skip to main content

Table 2 Tracing of the effects of combined therapy on AFP, number and size of focal lesions during the follow up period

From: Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience

 

1 month

4th month

7th month

10th month

Basal

AFP

57 ± 17.5

6.9 ± 1.5

7.1 ± 1.1

21.3 ± 9.4

6211.3 ± 929

p

(0.000)

(0.000)

(0.6)

(0.4)

No of lesions

2.4 ± 1

1.47 ± 0.6

0.93 ± 0.4

0.73 ± 0.34

2.5 ± 1.1

P

(p = 0.8)

(p = 0.000)

(p = 0.001)

(p = 0.2)

Size of lesions

6.4 ± 2.9

3.8 ± 1.8

2.2 ± 1.4

2.2 ± 0.9

10.4 ± 4.1

p

(p = 0.000)

(p = 0.000)

(p = 0.001)

(p = 0.8)